These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34700224)

  • 1. White adipocyte-targeted dual gene silencing of FABP4/5 for anti-obesity, anti-inflammation and reversal of insulin resistance: Efficacy and comparison of administration routes.
    Chung JY; Hong J; Kim HJ; Song Y; Yong SB; Lee J; Kim YH
    Biomaterials; 2021 Dec; 279():121209. PubMed ID: 34700224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of CRISPR interference system against
    Chung JY; Ain QU; Song Y; Yong SB; Kim YH
    Genome Res; 2019 Sep; 29(9):1442-1452. PubMed ID: 31467027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi-mediated germline knockdown of FABP4 increases body weight but does not improve the deranged nutrient metabolism of diet-induced obese mice.
    Yang R; Castriota G; Chen Y; Cleary MA; Ellsworth K; Shin MK; Tran JL; Vogt TF; Wu M; Xu S; Yang X; Zhang BB; Berger JP; Qureshi SA
    Int J Obes (Lond); 2011 Feb; 35(2):217-25. PubMed ID: 20603627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligopeptide complex for targeted non-viral gene delivery to adipocytes.
    Won YW; Adhikary PP; Lim KS; Kim HJ; Kim JK; Kim YH
    Nat Mater; 2014 Dec; 13(12):1157-64. PubMed ID: 25282508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabp4-Cre-mediated
    Xiong X; Zhang C; Zhang Y; Fan R; Qian X; Dong XC
    J Endocrinol; 2017 Jun; 233(3):307-314. PubMed ID: 28385723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cytoskeletal protein septin 11 is associated with human obesity and is involved in adipocyte lipid storage and metabolism.
    Moreno-Castellanos N; Rodríguez A; Rabanal-Ruiz Y; Fernández-Vega A; López-Miranda J; Vázquez-Martínez R; Frühbeck G; Malagón MM
    Diabetologia; 2017 Feb; 60(2):324-335. PubMed ID: 27866222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between Fatty Acid-Binding Protein 4⁻A Proinflammatory Adipokine and Insulin Resistance, Gestational and Type 2 Diabetes Mellitus.
    Trojnar M; Patro-Małysza J; Kimber-Trojnar Ż; Leszczyńska-Gorzelak B; Mosiewicz J
    Cells; 2019 Mar; 8(3):. PubMed ID: 30857223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome and Metabolome Analyses in Exogenous FABP4- and FABP5-Treated Adipose-Derived Stem Cells.
    Yamamoto T; Furuhashi M; Sugaya T; Oikawa T; Matsumoto M; Funahashi Y; Matsukawa Y; Gotoh M; Miura T
    PLoS One; 2016; 11(12):e0167825. PubMed ID: 27936164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral adipose tissue macrophage-targeted TACE silencing to treat obesity-induced type 2 diabetes.
    Yong SB; Song Y; Kim YH
    Biomaterials; 2017 Dec; 148():81-89. PubMed ID: 28985514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity.
    Lan H; Cheng CC; Kowalski TJ; Pang L; Shan L; Chuang CC; Jackson J; Rojas-Triana A; Bober L; Liu L; Voigt J; Orth P; Yang X; Shipps GW; Hedrick JA
    J Lipid Res; 2011 Apr; 52(4):646-56. PubMed ID: 21296956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unconventional Secretion of Adipocyte Fatty Acid Binding Protein 4 Is Mediated By Autophagic Proteins in a Sirtuin-1-Dependent Manner.
    Josephrajan A; Hertzel AV; Bohm EK; McBurney MW; Imai SI; Mashek DG; Kim DH; Bernlohr DA
    Diabetes; 2019 Sep; 68(9):1767-1777. PubMed ID: 31171562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Expression and Correlation of Pten and Fabp4 in Liver, Muscle, and Adipose Tissues of Type 2 Diabetes Rats.
    Su D; Zhang CL; Gao YC; Liu XY; Li CP; Huangfu J; Xiao R
    Med Sci Monit; 2015 Nov; 21():3616-21. PubMed ID: 26591002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose-specific Vdr deletion alters body fat and enhances mammary epithelial density.
    Matthews DG; D'Angelo J; Drelich J; Welsh J
    J Steroid Biochem Mol Biol; 2016 Nov; 164():299-308. PubMed ID: 26429395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FABP4 dynamics in obesity: discrepancies in adipose tissue and liver expression regarding circulating plasma levels.
    Queipo-Ortuño MI; Escoté X; Ceperuelo-Mallafré V; Garrido-Sanchez L; Miranda M; Clemente-Postigo M; Pérez-Pérez R; Peral B; Cardona F; Fernández-Real JM; Tinahones FJ; Vendrell J
    PLoS One; 2012; 7(11):e48605. PubMed ID: 23139800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LMO3 reprograms visceral adipocyte metabolism during obesity.
    Wagner G; Fenzl A; Lindroos-Christensen J; Einwallner E; Husa J; Witzeneder N; Rauscher S; Gröger M; Derdak S; Mohr T; Sutterlüty H; Klinglmüller F; Wolkerstorfer S; Fondi M; Hoermann G; Cao L; Wagner O; Kiefer FW; Esterbauer H; Bilban M
    J Mol Med (Berl); 2021 Aug; 99(8):1151-1171. PubMed ID: 34018016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Insight into Fatty Acid Binding Protein 4 Mechanisms and Therapeutic Implications in Obesity-Associated Diseases: A Mini Review.
    Başarır Sivri FN; Çiftçi S
    Mol Nutr Food Res; 2024 Apr; 68(8):e2300840. PubMed ID: 38593305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.
    Furuhashi M
    J Atheroscler Thromb; 2019 Mar; 26(3):216-232. PubMed ID: 30726793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulative effect of maternal serum fatty acid-binding protein 4 on insulin resistance and the development of gestational diabetes mellitus.
    Duan B; Li Y; Dong K; Sun Y; Ma A; Yang X
    Prostaglandins Leukot Essent Fatty Acids; 2020 Dec; 163():102213. PubMed ID: 33260074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of new dual FABP4/5 inhibitors based on a naphthalene-1-sulfonamide FABP4 inhibitor.
    He Y; Dou H; Gao D; Wang T; Zhang M; Wang H; Li Y
    Bioorg Med Chem; 2019 Oct; 27(19):115015. PubMed ID: 31420256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of FABP4/5 inhibitors with potential therapeutic effect on type 2 Diabetes Mellitus.
    He YL; Chen MT; Wang T; Zhang MM; Li YX; Wang HY; Ding N
    Eur J Med Chem; 2021 Nov; 224():113720. PubMed ID: 34332399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.